Bicycle Therapeutics Plc (BCYC)
3.805
-0.08
(-2.19%)
USD |
NASDAQ |
Oct 12, 16:00
3.80
0.00 (0.00%)
After-Hours: 19:11
Bicycle Therapeutics Free Cash Flow (Quarterly) : -49.96M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -49.96M |
| March 31, 2026 | -66.53M |
| December 31, 2025 | -19.67M |
| September 30, 2025 | -71.31M |
| June 30, 2025 | -74.33M |
| March 31, 2025 | -87.31M |
| December 31, 2024 | -9.132M |
| September 30, 2024 | -40.93M |
| June 30, 2024 | -45.12M |
| March 31, 2024 | -70.84M |
| December 31, 2023 | -47.51M |
| September 30, 2023 | -1.506M |
| June 30, 2023 | 34.17M |
| March 31, 2023 | -48.95M |
| December 31, 2022 | -33.88M |
| September 30, 2022 | -7.844M |
| June 30, 2022 | -32.44M |
| Date | Value |
|---|---|
| March 31, 2022 | -30.87M |
| December 31, 2021 | -9.360M |
| September 30, 2021 | 21.73M |
| June 30, 2021 | -12.33M |
| March 31, 2021 | -16.85M |
| December 31, 2020 | -17.43M |
| September 30, 2020 | -9.904M |
| June 30, 2020 | -12.46M |
| March 31, 2020 | 20.66M |
| December 31, 2019 | -5.400M |
| September 30, 2019 | -11.51M |
| June 30, 2019 | -7.878M |
| March 31, 2019 | -5.501M |
| December 31, 2018 | -9.210M |
| September 30, 2018 | -4.810M |
| June 30, 2018 | -5.597M |
| March 31, 2018 | -7.588M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Autolus Therapeutics Plc | -26.08M |
| Akari Therapeutics Plc | -3.112M |
| Cellectis SA | -14.59M |
| DBV Technologies SA | -49.68M |
| Biodexa Pharmaceuticals Plc | -- |